Evidences for anti-mycobacterium activities of lipids and surfactants

World Journal of Microbiology and Biotechnology

Volumn 32, Issue 1, 2016, Pages 1-17

  Hussain, Afzal ^a   Singh, Sandeep Kumar ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Atomic force microscopy; Histopathology; Mycobacterium smegmatis; Mycobacterium tuberculosis H37 Rv; Transmission electron microscopy

Indexed keywords

ATOMIC FORCE MICROSCOPY; BACTERIA; BLOOD; DIAGNOSIS; DRUG DOSAGE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIPIDS; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY;

AIRBORNE DISEASE; BACTERIAL KILLING; CONCENTRATION-DEPENDENT; FORCE MICROSCOPY; HISTOPATHOLOGY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; SYNERGISTIC ACTIVITY;

TUBES (COMPONENTS);

ACYLGLYCEROL; CAPMUL MCM C8; EXCIPIENT; LABRASOL; LIPID; SURFACTANT; TUBERCULOSTATIC AGENT;

ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; FEMALE; MALE; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MOUSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG SYNERGISM; EXCIPIENTS; FEMALE; GLYCERIDES; LIPIDS; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; SURFACE-ACTIVE AGENTS; TUBERCULOSIS;

EID: 84951919421     PISSN: 09593993     EISSN: 15730972     Source Type: Journal    
DOI: 10.1007/s11274-015-1965-4     Document Type: Article

References (45)

1. Arnold YE, Imanidis G, Kuentz M (2012) In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life. Drug Dev Ind Pharm 38(10):1262–1269
2. Barry III (2001) Mycobacterium smegmatis: an absurd model for tuberculosis? Trends Microbiol 9(10):472–473
3. Beg S, Jena SS, Patra CN et al (2013) Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Coll Surf B Biointerfaces 101:414–423
4. Bleck CK, Merz A, Gutierrez MG et al (2010) Comparison of different methods for thin section EM analysis of Mycobacteriumsmegmatis. J Microsc 237:23–38
5. Chang T, Benet LZ, Hebert MF (1996) The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 59:297–303
6. Dahl JL (2005) Scanning electron microscopy analysis of aged Mycobacteriumtuberculosis cells. Can J Microbiol 51:277–281
7. Dudeja PK, Anderson KM, Harris JS et al (1995) Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys 319:309–315
8. 2155: is there a clue for the unique transformability of the strain? Microbiology 151:2075–2086
9. Falamarzian A, Lavasanifar A (2010) Chemical modification of hydrophobic block in poly(ethyleneoxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B. Macromol Biosci 10:648–656
10. Fujiwara N, Naka T, Ogawa M et al (2012) Characteristics of Mycobacterium smegmatis J15cs strain lipids. Tuberculosis 92:187–192
11. Global Tuberculosis Report (2012) World Health Organization (WHO). www.who.int/tb. Accessed 29 Nov 2012
12. Global Tuberculosis Report (2013) World Health Organization (WHO). www.who.int/tb. Accessed on 24 Dec 2013
13. Global Tuberculosis Report (2014) World Health Organization (WHO). www.who.int/tb. Accessed 25 Nov 2014
14. Gopalaswamy R, Narayanan S, Jacobs WR Jr et al (2008) Mycobacterium smegmatis biofilm formation and sliding motility are affected by the serine/threonine protein kinase PknF. FEMS Microbiol Lett 278:121–127
15. Gupta R, Bandana Thakur B, Singh P et al (2010) Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res 131:809–813
16. Hanh ND, Mitrevej A, Sathirakul K et al (2013) Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm: doi:10.3109/03639045.2013.858732
17. Hassan A, Fattouh M, Atteya I, Mohammadeen H, Ahmed H (2014) Validation of A rapid tuberculosis PCR assay for detection of MDR-TB patients in sohag University Hospital. J Appl Environ Microbiol 2(3):65–69
18. Hussain A, Samad A, Nazish I et al (2013) Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 40(4):527–541
19. Immanuel G, Sivagnanavelmurugan M, Palavesam A (2011) Antibacterial effect of medium-chain fatty acid: caprylic acid on genotobiotic Artemia franciscana nauplii against shrimp pathogens Vibrio harveyi and V. parahaemolyticus. Aquac Int 19:91–101
20. Jain S, Jain P, Umamaheshwari RB, Jain NK (2003) Transfersomes a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013–1026
21. Jain S, Kaur A, Puri R et al (2010) Poly propyl ether imine (PETIM) dendrimer: a novel non-toxic dendrimer for sustained drug delivery. Eur J Med Chem 45(11):4997–5005
22. Jiang T, He L, Zhan Y (2011) The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacteriumsmegmatis. Microb Pathog 51:156–160
23. Kamdem SS, Guerzoni ME, Baranyi J et al (2011) Effect of capric, lauric and α-linolenic acids on the division time distributions of single cells of Staphylococcus aureus. Int J Food Microbiol 128(1):122–128
24. Kang J, Xu L, Yang S et al (2013) Effect of phosphoglucosamine mutase on biofilm formation and antimicrobial susceptibilities in M. smegmatis glmM gene knockdown strain. Plos One 8(4):e61589. doi:10.1371/journal.pone.0061589
25. Lin Y, Shen Q, Katsumi H et al (2007) Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine 123, a P-glycoprotein substrate, in rats. Biol Pharm Bull 30:1301–1307
26. Malik M, Lu T, Zhao X et al (2005) Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol. Antimicrob Agents Chemother 49(5):2008–2014
27. Mukherjee K, Tribedi P, Mukhopadhyay B et al (2013) Antibacterial activity of long-chain fatty alcohols against mycobacteria. FEMS Microbiol Lett 338(2):177–183
28. Nasr M, Taha I, Hathout RM (2013) Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Drug Deliv 20(8):311–318
29. Pandey R, Sharma S, Khuller GK (2006) Oral poly lactide co-glycolide nanoparticle based antituberculosis drug delivery: toxicological and chemotherapeutic implications. Indian J Exp Biol 44:459–467
30. Perkins WR, Richard B et al (1997) Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity. Biochim Biophys Acta 1327:61–68
31. Rahman MA, Hussain A, Hussain MS et al (2013) Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 39(1):1–19
32. Rege BD, Kao JPY, Polli JE (2002) Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 16:237–246
33. Schneider WC (1957) In: Colowick SP, Kaplan NO (eds) Methods in enzymology, vol Ill. Academic Press, New York, p 680
34. Shen Y, Lu Y, Jv M et al (2011) Enhancing effect of labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm 37(12):1415–1421
35. Singh N, Verma SM, Singh SK et al (2013a) Antibacterial action of lipidic nanoemulsions using atomic force microscopy and scanning electron microscopy on Escherichia coli. J Exp Nanosci 10(5):381–391
36. Singh N, Verma SM, Singh SK et al (2013b) Antibacterial activity of cationised and non-cationised placebo lipidic nanoemulsion using transmission electron microscopy. J Exp Nanosci 10(4):299–309
37. Singh N, Verma SM, Singh SK et al (2014) Consequences of lipidic nanoemulsions on membrane integrity and ultrastructural morphology of Staphylococcus aureus. Mater Res Express 1(02540):1. doi:10.1088/2053-1591/1/2/025401
38. Singh N, Verma SM, Singh SK et al (2015) Evidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeroginosa. Antonie Van Leeuwenhoek 107(6):1555–1568
39. Su HN, Chen Z-H, Song X-Y et al (2012) Antimicrobial peptide trichokonin VI-induced alterations in the morphological and nanomechanical properties of Bacillussubtilis. PLoS One 7(9):e45818
40. Verma S, Singh SK, Verm PRP et al (2014) Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm 40(10):1–13
41. Woodcock DM, Linsenmeyer ME, Chojnowski G et al (1992) Reversal of multidrug resistance by surfactants. Br J Cancer 66:62–68
42. Yang S, Zhang F, Kang J et al (2014) Mycobacteriumtuberculosis Rv1096 protein: gene cloning, protein expression and peptidoglycan deacetylase activity. BMC Microbiol 14:174
43. ® 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 26:768–772
44. Zhang H, Cui Y, Zhu S et al (2010) Characterization and antimicrobial activity of a pharmaceutical emulsion. Int J Pharm 395:154–160
45. Zuber B, Chami M, Houssin C, Dubochet J, Griffiths G, Daffé M (2008) Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J Bacteriol 190:5672–5680